Tilg, Herbert

Lipocalin 2 protects from inflammation and Tumorigenesis associated with gut microbiota alterations

Moschen, A. R., Gerner, R. R., Wang, J., Klepsch, V., Adolph, T. E., Reider, S. J., Hackl, H., Pfister, A., Schilling, J., Moser, P. L., et al. (2016) · Cell Host & Microbe

Gut microbiota and healthInflammatory Bowel Disease

Cited by 375

Non-alcoholic fatty liver disease and increased risk of incident extrahepatic cancers: a meta-analysis of observational cohort studies

Mantovani, A., Petracca, G., Beatrice, G., Csermely, A., Tilg, H., Byrne, C. D., & Targher, G. (2022) · Gut

Liver Disease Diagnosis and TreatmentCancer Risks and Factors

Cited by 363

Lipocalin-2: A Master Mediator of Intestinal and Metabolic Inflammation

Moschen, A. R., Adolph, T. E., Gerner, R. R., Wieser, V., & Tilg, H. (2017) · Trends in Endocrinology & Metabolism

Adipokines, Inflammation, and Metabolic DiseasesInflammation biomarkers and pathways

Cited by 359

SCORE2-Diabetes: 10-year cardiovascular risk estimation in type 2 diabetes in Europe

SCORE2-Diabetes Working Group and the ESC Cardiovascular Risk Collaboration, Pennells, L., Kaptoge, S., Østergaard, H. B., Read, S. H., Carinci, F., Franch-Nadal, J., Petitjean, C., Taylor, O., Hageman, S. H. J., et al. (2023) · European Heart Journal

Diabetes, Cardiovascular Risks, and LipoproteinsHealth Promotion and Cardiovascular Prevention

Cited by 329

Risk of cardiomyopathy and cardiac arrhythmias in patients with nonalcoholic fatty liver disease

Anstee, Q. M., Mantovani, A., Tilg, H., & Targher, G. (2018) · Nature Reviews Gastroenterology & Hepatology

Liver Disease Diagnosis and TreatmentCardiovascular Function and Risk Factors

Cited by 310

Dietary lipids fuel GPX4-restricted enteritis resembling Crohn’s disease

Mayr, L., Grabherr, F., Schwärzler, J., Reitmeier, I., Sommer, F., Gehmacher, T., Niederreiter, L., He, G.-W., Ruder, B., Kunz, K. T. R., et al. (2020) · Nature Communications

Inflammatory Bowel DiseaseGut microbiota and health

Cited by 292

Food, immunity, and the microbiome

Tilg, H., & Moschen, A. R. (2015) · Gastroenterology

Gut microbiota and healthNutritional Studies and Diet

Cited by 292

Gut, inflammation and osteoporosis: Basic and clinical concepts

Tilg, H., Moschen, A. R., Kaser, A., Pines, A., & Dotan, I. (2008) · Gut

Bone Metabolism and DiseasesInflammatory Bowel Disease

Cited by 292

Association of the COVID-19 pandemic with internet search volumes: a Google Trends™ analysis

Effenberger, M., Kronbichler, A., Shin, J. I., Mayer, G., Tilg, H., & Perco, P. (2020) · International Journal of Infectious Diseases

Data-Driven Disease SurveillanceCOVID-19 epidemiological studies

Cited by 270

Dietary spermidine improves cognitive function

Schroeder, S., Hofer, S. J., Zimmermann, A., Pechlaner, R., Dammbrueck, C., Pendl, T., Marcello, G. M., Pogatschnigg, V., Bergmann, M., Müller, M., et al. (2021) · Cell Reports

Genetics, Aging, and Longevity in Model OrganismsPolyamine Metabolism and Applications

Cited by 225

Erythropoietin Contrastingly Affects Bacterial Infection and Experimental Colitis by Inhibiting Nuclear Factor-κB-Inducible Immune Pathways

Nairz, M., Schroll, A., Moschen, A. R., Sonnweber, T., Theurl, M., Theurl, I., Taub, N., Jamnig, C., Neurauter, D., Huber, L. A., et al. (2011) · Immunity

Erythropoietin and Anemia TreatmentNF-κB Signaling Pathways

Cited by 194

NAD metabolism fuels human and mouse intestinal inflammation

Gerner, R. R., Klepsch, V., Macheiner, S., Arnhard, K., Adolph, T. E., Grander, C., Wieser, V., Pfister, A., Moser, P., Hermann-Kleiter, N., et al. (2018) · Gut

Sirtuins and Resveratrol in MedicineInflammatory Bowel Disease

Cited by 192

Role of IL-10 for induction of anemia during inflammation

Tilg, H., Ulmer, H., Kaser, A., & Weiss, G. (2002) · The Journal of Immunology

Iron Metabolism and DisordersErythropoietin and Anemia Treatment

Cited by 181

Dietary Factors: Major Regulators of the Gut's Microbiota

Moschen, A. R., Wieser, V., & Tilg, H. (2012) · Gut and Liver

Gut microbiota and healthNutritional Studies and Diet

Cited by 173

Reorganisation of Faecal Microbiota Transplant Services During the COVID-19 Pandemic

Ianiro, G., Mullish, B. H., Kelly, C. R., Kassam, Z., Kuijper, E. J., Ng, S. C., Iqbal, T. H., Allegretti, J. R., Bibbò, S., Sokol, H., et al. (2020) · Gut

Clostridium difficile and Clostridium perfringens researchGut microbiota and health

Cited by 147

The first international Rome consensus conference on gut microbiota and faecal microbiota transplantation in inflammatory bowel disease

Lopetuso, L. R., Deleu, S., Godny, L., Petito, V., Puca, P., Facciotti, F., Sokol, H., Ianiro, G., Masucci, L., Abreu, M., et al. (2023) · Gut

Inflammatory Bowel DiseaseGut microbiota and health

Cited by 129

Non-alcoholic fatty liver disease and risk of new-onset heart failure: an updated meta-analysis of about 11 million individuals

Mantovani, A., Petracca, G., Csermely, A., Beatrice, G., Bonapace, S., Rossi, A., Tilg, H., Byrne, C. D., & Targher, G. (2023) · Gut

Liver Disease Diagnosis and TreatmentHeart Failure Treatment and Management

Cited by 128

Faecal Biomarkers in Inflammatory Bowel Diseases: Calprotectin Versus Lipocalin-2-a Comparative Study

Zollner, A., Schmiderer, A., Reider, S. J., Oberhuber, G., Pfister, A., Texler, B., Watschinger, C., Koch, R., Effenberger, M., Raine, T., et al. (2021) · Journal of Crohn's and Colitis

Inflammatory Bowel DiseaseOcular Diseases and Behçet’s Syndrome

Cited by 95

Norursodeoxycholic acid versus placebo in the treatment of non-alcoholic fatty liver disease: a double-blind, randomised, placebo-controlled, phase 2 dose-finding trial

Traussnigg, S., Schattenberg, J. M., Demir, M., Wiegand, J., Geier, A., Teuber, G., Hofmann, W. P., Kremer, A. E., Spreda, F., Kluwe, J., et al. (2019) · The Lancet Gastroenterology & Hepatology

Liver Disease Diagnosis and TreatmentLiver Diseases and Immunity

Cited by 88

NASH drug treatment development: challenges and lessons

Tilg, H., Byrne, C. D., & Targher, G. (2023) · The Lancet Gastroenterology & Hepatology

Liver Disease Diagnosis and TreatmentAlcohol Consumption and Health Effects

Cited by 81

Adiponectin: a key fat-derived molecule regulating inflammation

Tilg, H., & Wolf, A. M. (2005) · Expert Opinion on Therapeutic Targets

Adipokines, Inflammation, and Metabolic DiseasesPeroxisome Proliferator-Activated Receptors

Cited by 71

Lipocalin‐2 ensures host defense against Salmonella Typhimurium by controlling macrophage iron homeostasis and immune response

Nairz, M., Schroll, A., Haschka, D., Dichtl, S., Sonnweber, T., Theurl, I., Theurl, M., Lindner, E., Demetz, E., Aßhoff, M., et al. (2015) · European Journal of Immunology

Immune Response and InflammationIron Metabolism and Disorders

Cited by 67

Innate Immunity and MASLD

Meyer, M., Schwärzler, J., Jukic, A., & Tilg, H. (2024) · Biomolecules

Liver Disease Diagnosis and TreatmentLiver physiology and pathology

Cited by 50

Interferon-alpha and its effects on the cytokine cascade: a pro- and anti-inflammatory cytokine

Tilg, H., & Peschel, C. (1996) · Leukemia & Lymphoma

interferon and immune responsesCytokine Signaling Pathways and Interactions

Cited by 34